ROTAMAX

This brand name is authorized in Nigeria.

Active ingredients

The drug ROTAMAX contains one active pharmaceutical ingredient (API):

1	Azithromycin UNII 5FD1131I7S - AZITHROMYCIN DIHYDRATE
	Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.
	Read more about Azithromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100607	Suspension	ROTAMAX SUSPENSION SUSP 200 mg/5 mL 15ML	135 NF-PP-338058 ROTAMAX SUSPENSION Azithromycin For Oral Suspension USP 200mg/5ml AZITHROMYCIN FOR ORAL SUSPENSION USP 200MG, EXIPIENTS Q.S A4-100607 Drugs Imported Products 15ML POM 2 6/26/2023 ROTAMEDICS PHARMACY LIMITED, RESERVATION ROAD G.R.A ILORIN ILORIN KWARA 7055888798 rotamedics@gmail.com M/S RELAX BIOTECH.PVT.LTD, 862/1 G.I.D.C., MAKARPURA BARODA-390010 INDIA, India	30/11/2023
A4-100822	Tablet	ROTAMAX AZITHROMYCIN 250MG TABLETS TAB 250 mg 1 X 6	54 NF-PP-378578 ROTAMAX AZITHROMYCIN 250MG TABLETS AZITHROMYCIN 250MG AZITHROMYCIN DIHYDRATE 263MG, PRE GELATINIZED STARCH 16MG, MAIZE STARCH(F/P) 15MG, POVIDONE K-30% 8MG, PURIFIED WATER QS, COLLOIDAL SILICON DIOXIDE 1MG, MAGNESIUM STEARATE 3MG, KYRON T-314 6MG, ISOPROPYL ALCOHOL QS, READY MIX OF IRON OXIDE YELLOW 19MG, METHYLENE CHLORIDE QS A4-100822 Drugs Imported Products 250MG Prescription Only Medicine (POM) ROTAMEDICS PHARMACY LIMITED, RESERVATION ROAD G.R.A ILORIN ILORIN KWARA 7055888798 rotamedics@gmail.com M/s. RELAX BIOTECH PVT LTD, 862/1, G.I.D.C., MAKARPURA, City: VADODARA 391010, Dist.: VADODARA GUJARAT STATE, INDIA., India	30/04/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA10	Azithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100607, A4-100822